Ramona, CA, United States of America

Mark Eben Massari

USPTO Granted Patents = 2 


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mark Eben Massari: Innovator in Therapeutic Compounds

Introduction

Mark Eben Massari is a notable inventor based in Ramona, CA (US). He has made significant contributions to the field of therapeutic compounds, holding 2 patents that focus on innovative chemical entities for medical use. His work aims to address various neurological and peripheral disorders, showcasing his commitment to improving health outcomes.

Latest Patents

Massari's latest patents include compounds for therapeutic use, specifically chemical entities of Formula (I). These compounds, including their enantiomers, are designed for various applications, including the treatment of depression, pain, cognitive disorders, neurodegenerative disorders, and other neurological and peripheral disorders. His research emphasizes the preparation and use of these chemical entities in effective treatment methods.

Career Highlights

Throughout his career, Mark Eben Massari has been associated with Dart Neuroscience, LLC, where he has focused on developing innovative solutions in the field of neuroscience. His expertise in therapeutic compounds has positioned him as a key player in advancing medical research and treatment options.

Collaborations

Massari collaborates with Laurent Gomez, contributing to the development of groundbreaking therapeutic solutions. Their partnership exemplifies the importance of teamwork in the pursuit of innovation in the medical field.

Conclusion

Mark Eben Massari's work in therapeutic compounds highlights his dedication to addressing critical health issues through innovation. His patents and collaborations reflect a commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…